Underutilization of Heart Failure Guidelines Poses Global Health Risk
UCLA-led research underscores the underutilization of guideline-directed medical therapy for heart failure with reduced ejection fraction worldwide.
UCLA-led research underscores the underutilization of guideline-directed medical therapy for heart failure with reduced ejection fraction worldwide.
A clinical trial found that an investigational drug improved exercise capacity in patients with hypertrophic cardiomyopathy by increasing their peak oxygen uptake.
The Centers for Medicare and Medicaid Services announced that it would allow health plans under Medicare Part D to cover Wegovy and other weight-loss medications if they receive FDA approval for an additional medically accepted indication.
Read MoreA new study in mice suggests regular use of acetaminophen, the active ingredient in Tylenol and many other pain medications, at moderate to high doses may pose a risk to heart health.
Read MoreA new study shows treating anxiety and depression can lead to a 75% reduction in emergency room visits and rehospitalizations for heart disease patients.
Read MoreAprocitentan, targeting the endothelin pathway, offers a new approach for managing hypertension alongside existing medications.
Read MoreThe drug, which also treats enlarged prostate, may also lower cholesterol and cut the overall risk of heart disease.
Read MoreA cardiologist answers questions about how these highly publicized medications may impact cardiovascular health.
Read MoreInvestigators say there was no statistically significant difference between the effectiveness of the two methods, with each patient group experiencing a more than 50% reduction in the severity of depressive symptoms.
Read MoreCedars-Sinai investigators suggest it may be helpful to keep an eye on patients with underlying health issues after COVID-19 vaccination to monitor for post-vaccine POTS, a condition that causes an abnormal increase in heart rate after standing or sitting up.
Read MoreThe common heart medication digoxin enhances survival rates in infants undergoing surgery for single-ventricle heart defects, according to new research.
Read More